China wants 5 innovative drugs with US$1 billion returns by 2030. Which might they be?

Beijing is attempting to have at least five pharmaceutical products with annual global sales of more than US$1 billion.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.